Enhanced Cell Migration: TB-500's interaction with actin complements BPC-157's effects on the FAK-paxillin pathway for improved wound closure
What the preclinical research actually shows Because PDA shares the BPC-157 sequence, its proposed biological activity is drawn entirely from the BPC-157 preclinical literature
Toxicon 82:97103 Park MH, Jo M, Won D et al (2012) Snake venom toxin from Vipera lebetina turanica sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins
Drug manufacturers design subcutaneous medications knowing that patients will use different injection sites, and they ensure the therapeutic window is wide enough to accommodate these normal variations
Red Flags to Watch For If you are taking GLP-1s, these warning signs suggest the medication may be interfering with recovery: Using medication effects as justification to eat less than planned or skip meals Feeling relief at having a medical reason not to eat Increased eating disorder thoughts about food, weight, or body image Return of any eating disorder behaviors (restriction beyond medication effects, purging, excessive exercise, body checking) Hiding eating patterns or medication use from your treatment team Rapid or excessive weight loss Increased anxiety around food or eating situations If you notice any of these, talk to your treatment team immediately
